Global Infectious Diseases Diagnostics Market to reach USD 25.07 billion by 2026

Global Infectious Diseases Diagnostics Market Size Study, by Product & Service (Assays Kits & Reagents, Instruments, Services & Software) by Technology (Immunodiagnostics , Clinic Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid, Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing, DNA Microarray , Other technologies) by Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG), Hospital-Acquired Infection (HAIS), Tuberculosis, Influenza, Other Infectious Diseases) by End-User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/ Research Institutes, Other End-User) by Regional Forecasts 2019-2026
Product Code:  HALMD_88176624
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Infectious Disease Diagnostics Market, by Product & Services, 2017-2026 (USD Billion)
1.2.2.	Infectious Disease Diagnostics Market, by Technology, 2017-2026 (USD Billion)
1.2.3.	Infectious Disease Diagnostics Market, by Disease Type, 2017-2026 (USD Billion)
1.2.4.	Infectious Disease Diagnostics Market, by End-User, 2017-2026 (USD Billion)
1.2.5.	Infectious Disease Diagnostics Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Infectious Disease Diagnostics Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Infectious Disease Diagnostics Market Dynamics	
3.1.	Infectious Disease Diagnostics Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Infectious Disease Diagnostics Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Infectious Disease Diagnostics Market, by Product & Services
5.1.	Market Snapshot 
5.2.	Global Infectious Disease Diagnostics Market by Product & Services, Performance - Potential Analysis
5.3.	Global Infectious Disease Diagnostics Market Estimates & Forecasts by Product & Services, 2016-2026 (USD Billion)
5.4.	Infectious Disease Diagnostics Market, Sub Segment Analysis
5.4.1.	Assays Kits & Reagents 
5.4.2.	Instruments 
5.4.3.	Services & Software
Chapter 6.	Global Infectious Disease Diagnostics Market, by Technology
6.1.	Market Snapshot 
6.2.	Global Infectious Disease Diagnostics Market by Technology, Performance - Potential Analysis
6.3.	Global Infectious Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
6.4.	Infectious Disease Diagnostics Market, Sub Segment Analysis
6.4.1.	Immunodiagnostics 
6.4.2.	Clinic Microbiology 
6.4.3.	Polymerase Chain Reaction (PCR)
6.4.4.	Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4.5.	DNA Sequencing & Next-Generation Sequencing 
6.4.6.	DNA Microarray 
6.4.7.	Other technologies
Chapter 7.	Global Infectious Disease Diagnostics Market, by Disease Type 
7.1.	Market Snapshot 
7.2.	Global Infectious Disease Diagnostics Market by Technology, Performance - Potential Analysis
7.3.	Global Infectious Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
7.4.	Infectious Disease Diagnostics Market, Sub Segment Analysis
7.4.1.	Hepatitis 
7.4.2.	Human Immunodeficiency Virus (HIV)
7.4.3.	Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG)
7.4.4.	Hospital-Acquired Infection (HAIS)
7.4.5.	Tuberculosis 
7.4.6.	Influenza 
7.4.7.	Other Infectious Diseases
Chapter 8.	Global Infectious Disease Diagnostics Market, by End-User
8.1.	Market Snapshot 
8.2.	Global Infectious Disease Diagnostics Market by End-User, Performance - Potential Analysis
8.3.	Global Infectious Disease Diagnostics Market Estimates & Forecasts by End-User, 2016-2026 (USD Billion)
8.4.	Infectious Disease Diagnostics Market, Sub Segment Analysis
8.4.1.	Hospital/Clinical Laboratories 
8.4.2.	Reference Laboratories 
8.4.3.	Physician Offices 
8.4.4.	Academic/ Research Institutes 
8.4.5.	Other End-User
Chapter 9.	Global Infectious Disease Diagnostics Market, Regional Analysis
9.1.	Infectious Disease Diagnostics Market, Regional Market Snapshot 
9.2.	North America Infectious Disease Diagnostics Market 
9.2.1.	U.S. Infectious Disease Diagnostics Market
9.2.1.1.	Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2.	Technology breakdown estimates & forecasts, 2016-2026
9.2.1.3.	Disease Type breakdown estimates & forecasts, 2016-2026
9.2.1.4.	End-User breakdown estimates & forecasts, 2016-2026
9.2.2.	Canada Infectious Disease Diagnostics Market
9.3.	Europe Infectious Disease Diagnostics Market Snapshot
9.3.1.	U.K. Infectious Disease Diagnostics Market
9.3.2.	Germany Infectious Disease Diagnostics Market
9.3.3.	Rest of Europe Infectious Disease Diagnostics Market
9.4.	Asia-Pacific Infectious Disease Diagnostics Market Snapshot
9.4.1.	China Infectious Disease Diagnostics Market 
9.4.2.	India Infectious Disease Diagnostics Market 
9.4.3.	Japan Infectious Disease Diagnostics Market
9.4.4.	Rest of Asia Pacific Infectious Disease Diagnostics Market
9.5.	Latin America Infectious Disease Diagnostics Market Snapshot
9.5.1.	Brazil Infectious Disease Diagnostics Market
9.5.2.	Mexico Infectious Disease Diagnostics Market
9.6.	Rest of The World Infectious Disease Diagnostics Market
Chapter 10.	Competitive Intelligence
10.1.	Top Market Strategies
10.2.	Company Profiles
10.2.1.	Abbott Laboratories
10.2.1.1.	Overview
10.2.1.2.	Financial (Subject to Data Availability)
10.2.1.3.	Product & Services Summary
10.2.1.4.	Recent Developments
10.2.2.	Becton, Dickinson & Company 
10.2.3.	Bio-Rad Laboratories 
10.2.4.	Danaher Corporation 
10.2.5.	Diasorin 
10.2.6.	Luminex 
10.2.7.	Meridian Bioscience 
10.2.8.	Quidel 
10.2.9.	Roche Diagnostics 
10.2.10.	Siemens AG
Chapter 11.	 Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.2.	Research Attributes
11.3.	Research Assumption

Global Infectious Diseases Diagnostics Market valued approximately USD 15.73 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2019-2026. Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens and molecular methods. Also, infectious disease diagnostics are several techniques used by professionals to diagnose and detect pathogens in human samples such as throat swab, urine, serum, blood, and stool. Growing prevalence of infectious diseases across the globe, increasing funding for research for infectious disease diagnostics and the change in focus from centralized laboratories to decentralized point-of-care testing are the few factor responsible for high CAGR of the market during the forecast period. For instance, In the United States, it is estimated that symptomatic illness of influenza is nearly 30,000,000 during 2016-17 which is to be increased to approximately 49,000,000 in 2017-18, as per the survey of Center for Disease Control and Prevention. Further, it is estimated that the incidence of TB is 1,04,00,000 in 2016, globally. Due to growing prevalence of infectious disease, it is likely to project the demand for infectious disease diagnostics across the globe. However, inadequate reimbursements and rising healthcare costs limiting the use of novel diagnostic techniques are the few factors limiting the growth of the market over the forecast period.

The regional analysis of Global Infectious Disease Diagnostics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America holds the leading position in terms of revenue in human liver model market. Factors such as wide presence of a well-developed healthcare system, growing incidences of infectious diseases, and the broad presence of a large number of leading national clinical laboratories are some key factors driving the growth of the North America. Whereas, Asia-Pacific is expected to emerge as a lucrative region for global human liver model market. The growth of the Asia-Pacific region is supplemented by the high prevalence of infectious diseases, and patient awareness among individual in the region.

Major manufacturers involved in this market are-
Abbott Laboratories
Becton, Dickinson & Company
Bio-Rad Laboratories
Danaher Corporation
Diasorin
Luminex
Meridian Bioscience
Quidel
Roche Diagnostics
Siemens AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:
Assays Kits & Reagents
Instruments
Services & Software

By Technology:

Immunodiagnostics
Clinic Microbiology
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing
DNA Microarray
Other Technologies

By Diseases Type:
Hepatitis
Human Immunodeficiency Virus (HIV)
Chlamydia Trachomatis Genital Infection & Gonorrhea
Hospital-Acquired Infection (HAIS)
Tuberculosis
Influenza
Other Infectious Diseases

By End-Use:
Hospitals/Clinical Laboratories
Reference Laboratories
Physician Offices
Academic/Research Institutes
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…